Australia markets closed

Kukje Pharma Co., Ltd. (002720.KS)

KSE - KSE Delayed price. Currency in KRW
Add to watchlist
4,940.00-55.00 (-1.10%)
At close: 03:30PM KST

Kukje Pharma Co., Ltd.

96-8, Yatap-ro
Bundang-gu
Seongnam-si
South Korea
82 3 1781 9081
https://www.kukjepharm.co.kr

Sector(s)Healthcare
IndustryDrug Manufacturers - Specialty & Generic
Full-time employees

Key executives

NameTitlePayExercisedYear born
Tae-hoon NamChief Executive OfficerN/AN/AN/A
Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in KRW.

Description

Kukje Pharma Co., Ltd. engages in manufacturing, importing, exporting, selling, and distributing pharmaceutical products. The company offers pharmaceutical products, including ETC and OTC products, raw materials, intermediates, and side chain products, as well as cosmetics and health care products. Its products include cephalosporins, quinolones, tetracycline, aminoglycosides, macrolides, other antibiotics, ophthalmic, antifungal and antiviral agents, ophthalmic agents, adrenal corticosteroids, CNS and osteoporotic agents, antihistamines, NSAIDS and other analgesics, gastrointestinal and cardiovascular agents, antidiabetics, genitourinary and respiratory agents, other ETC products, and other products. Kukje Pharma Co., Ltd. was founded in 1959 and is headquartered in Seongnam-si, South Korea.

Corporate governance

Kukje Pharma Co., Ltd.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.